Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells

Overview of attention for article published in Cell & Bioscience, April 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,066 followers.

🤔 Need a new therapeutic approach for patients with advanced colorectal cancer (CRC)? 👀 Dr. Maguy Del Rio and team identify Claudin-1 (#CLDN1) as a new biomarker of acquired resistance to #chemotherapy in #CRC patients 📖 Find out what they learned: 📍 htt

25 Apr 2023

Reply Repost Favourite

Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells https://t.co/xKifk3vvvy

12 Apr 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.